Company intelligence / Profile preview

Oftalvist

Ownership: Private
Development stage: Commercial

Overview

Oftalvist operates over 40 advanced ophthalmology clinics across Spain, providing comprehensive eye care including prevention, diagnosis, and treatment of ocular diseases. The group sees more than 75,000 new patients annually. It is recognized for pioneering work in artificial vision devices and participates in collaborative research on gene therapy and cell therapy for retinal diseases.

Therapeutic areas: Ophthalmology
Modalities: DeviceCell therapyGene therapy
Industry: Non-Academic Healthcare

Partnerships

Academic institutions such as Autonomous University of BarcelonaInstitute of NanotechnologyInstitute of High Energy PhysicsInstitute of Photonic SciencesUniversité de Genève Department of Nuclear and Corpuscular Physics Geneva SwitzerlandMayo Clinic Rochester Minnesota USANovartis Lab USA

Beyond the preview

Go deeper on Oftalvist.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oftalvist.

Explore the full profile